Search Within

Niamh Marie Keegan

Formats
  1. Meeting Abstract (10)
  2. Journal Article (7)
  3. Review (2)
Groups
  1. GME, Medicine (19)
  2. Graduate Medical Education (19)
  3. Department of Medicine (18)
  4. Solid Tumor Oncology Division (18)
  5. Genitourinary Oncology Service (17)
  6. Biostatistics Service (8)

More Groups

People
  1. Howard Scher (8)
  2. Emily Carbone (7)
  3. Ethan Barnett (7)
  4. Gopakumar Iyer (6)
  5. Jonathan Rosenberg (6)
  6. Samuel Funt (6)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (1)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Annals of Oncology (2)
  3. Cancer Medicine (1)
  4. Cancer Research (1)
  5. ESMO Open (1)
  6. European Urology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Oxford University Press (2)
  3. American Association for Cancer Research (1)
  4. American Association for the Advancement of Science (1)
  5. Elsevier B.V. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Meeting Abstract

    Keegan, N. M.; Vasselman, S. E.; Barnett, E.; Nweji, B.; Carbone, E.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Chromosomal instability (CIN) biomarker in circulating tumor cells (CTC) may predict for therapy resistance in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Keegan, N. M.; Schonhoft, J.; Barnett, E.; Cohn, E. D.; Zhao, J. L.; Carbone, E. A.; Zanone, M. R.; Anderson, A.; Wenstrup, R.; Scher, H. I.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
    Journal Article

    Shen, R.; Postow, M. A.; Adamow, M.; Arora, A.; Hannum, M.; Maher, C.; Wong, P.; Curran, M. A.; Hollmann, T. J.; Jia, L.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • Features consistent with a small-cell neuroendocrine like (SC/NE-L) transformation can be readily detected and quantified in circulating tumor cells (CTCs)
    Meeting Abstract

    Scher, H. I.; Jendrisak, A.; Gilbertson, C.; Gill, A.; Barnett, E.; Gopalan, A.; Keegan, N.; Zaidi, S.; Benoliel, H.; Emily, C.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Seek and find: Current prospective evidence for prostate-specific membrane antigen imaging to detect recurrent prostate cancer
    Review

    Keegan, N. M.; Bodei, L.; Morris, M. J.
    European Urology Focus (2021)

    Fulltext@MSK | Save
  • Prevalence of insomnia in an oncology patient population: An Irish tertiary referral center experience
    Journal Article

    Harrold, E. C.; Idris, A. F.; Keegan, N. M.; Corrigan, L.; Teo, M. Y.; O'Donnell, M.; Lim, S. T.; Duff, E.; O'Donnell, D. M.; Kennedy, M. J.; more...
    Journal of the National Comprehensive Cancer Network (2020)

    Fulltext@MSK | Save
  • Immune-related adverse events of checkpoint inhibitors
    Review

    Ramos-Casals, M.; Brahmer, J. R.; Callahan, M. K.; Flores-Chávez, A.; Keegan, N.; Khamashta, M. A.; Lambotte, O.; Mariette, X.; Prat, A.; Suárez-Almazor, M. E.
    Nature Reviews Disease Primers (2020)

    Fulltext@MSK | Save
  • Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
    Journal Article

    Gleeson, J. P.; Keane, F.; Keegan, N. M.; Mammadov, E.; Harrold, E.; Alhusaini, A.; Harte, J.; Eakin-Love, A.; O'Halloran, P. J.; MacNally, S.; more...
    Cancer Medicine (2020)

    Fulltext@MSK | Save
  • Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Keegan, N. M.; Funt, S. A.; Kania, B. E.; Iyer, G.; Clement, J. M.; McCoy, A. S.; Hettich, G.; Ziv, E.; Maher, C. A.; Nair, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save